Skip to content
    EDBI logo

    EDBI

    SingaporeFounded 1991

    EDBI is the strategic investment arm of the Singapore Economic Development Board, focusing on high-growth technology sectors such as Information & Communication Technology, Emerging Technology, and Healthcare. Their strategy involves providing growth capital to innovative companies looking to expand in Asia and globally through Singapore, with a dual mandate of achieving financial returns and creating economic value and employment opportunities in Singapore.

    Deal activity increased 150% year-over-year (5 deals in the last 12 months). Average disclosed round size is $109.6M (across 52 rounds with reported amounts).

    Find people at EDBI on Goldilocks AI

    Portfolio

    52

    Fund Size

    Top Stage

    Series C

    Last 12 Mo

    5

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    52 investments
    CompanyRoundAmountDate
    Antheia logoAntheiaSeries C$24MJan 2026
    d-Matrix logod-MatrixSeries C$275MNov 2025
    Debut logoDebutUnknown$20MAug 2025
    Antheia logoAntheiaSeries C$56MJun 2025
    Addepar logoAddeparSeries G$230MMay 2025
    Riverlane logoRiverlaneSeries C$75MAug 2024
    Neko Health logoNeko HealthSeries D$41MJun 2024
    LXA logoLXASeed$10MNov 2023
    AlphaSense logoAlphaSenseSeries E$150MSep 2023
    Endowus logoEndowusSeries B$35MAug 2023
    Thunes logoThunesSeries C$72MJul 2023
    EdgeQ logoEdgeQSeries B$75MApr 2023
    RResolve BiosciencesSeries B$71MOct 2022
    Fazz logoFazzSeries C$100MSep 2022
    Aspen Neuroscience logoAspen NeuroscienceSeries B$147.5MMay 2022
    NNeuron MobilitySeries B$43.5MApr 2022
    Upside Foods logoUpside FoodsSeries C$400MApr 2022
    VVoyager InnovationsGrowth$210MApr 2022
    Beam logoBeamSeries B$93MFeb 2022
    Funding Societies logoFunding SocietiesSeries C$144MFeb 2022
    Next Gen Foods logoNext Gen FoodsSeries A$100MFeb 2022
    Ember logoEmberSeries E$23.5MDec 2021
    Endowus logoEndowusSeries B$25.6MNov 2021
    NNeuroglee TherapeuticsSeries A$10MSep 2021
    DDoctor AnywhereSeries C$65.7MAug 2021
    Page 1 of 3

    Top Co-Investors

    Last updated: 12 April 2026